Management of cardiogenic shock in the setting of ST-elevation myocardial infarction: controversies and future directions.
Journal Article (Review)
The treatment of patients with ST-segment elevation myocardial infarction (STEMI) has changed dramatically since reperfusion therapy has been adopted more commonly, yet 5-10% of patients still develop cardiogenic shock and remain a therapeutic challenge in the setting of STEMI. In this review, we outline the available evidence from randomized controlled trials and registries, including risk factors, diagnostic tools, and various treatments. The main focus of this report is on the currently available treatment options (revascularization, intra-aortic balloon counterpulsation), emerging treatment options (percutaneous hemodynamic support, extracorporeal membrane oxygenation), and ongoing efforts to design systems of care to more efficiently care for these patients.
Full Text
Duke Authors
Cited Authors
- Kohl, LP; Jones, WS
Published Date
- August 2015
Published In
Volume / Issue
- 63 / 4
Start / End Page
- 329 - 342
PubMed ID
- 26005212
Pubmed Central ID
- 26005212
Electronic International Standard Serial Number (EISSN)
- 1827-1618
Language
- eng
Conference Location
- Italy